Lung Nodules Clinical Trials

Find Lung Nodules Clinical Trials Near You

Study of Imaging Evolution of Pulmonary Nodules and Artificial Intelligence-Assisted Diagnostic and Management Strategies

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Patients with indeterminate lung nodules often face a choice between continued CT surveillance and invasive investigation. This trial compares management with or without access to an AI report that matches nodules across real serial CT scans, measures change, and estimates validated malignancy or invasiveness risks. The principal question is whether offering the report reduces lung resections that yield benign pathology over 24 months. Diagnostic delay, cancer stage, treatment opportunity, complications, and longer-term cancer outcomes are also assessed.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 35
Healthy Volunteers: f
View:

• \- 1. At least one persistent indeterminate pulmonary nodule measuring 6 to 30 mm on the latest clinically obtained CT; solid, part-solid, and pure ground-glass nodules are eligible. 2. Two CT examinations in total are already available: the latest within 30 days before randomization and an earlier examination 3 to 24 months before it. Both meet the frozen image-quality requirements for longitudinal comparison. 3. The current decision between continued surveillance and further investigation remains unresolved, with no mandatory urgent procedure or committed definitive treatment before randomization.

• 4\. The patient is potentially eligible for curative treatment if cancer is diagnosed, with an estimated life expectancy of at least five years independent of the study nodule. 5. Written informed consent and willingness to permit record retrieval and five-year contact.

Locations
Other Locations
China
Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
RECRUITING
Wuhan
Contact Information
Primary
Xiaoyu Han
xiaoyuhan1123@163.com
+86 18202771604
Time Frame
Start Date: 2025-01-01
Estimated Completion Date: 2027-12-01
Participants
Target number of participants: 6000
Treatments
Experimental: AI-Assisted Longitudinal Nodule Management
Usual care plus the locked AI report reviewed with the actual CT images.
No_intervention: Structured Usual Nodule Management
Serial CT comparison, clinical risk assessment, routine measurement tools, and guideline-based management without access to the trial AI report.
Related Therapeutic Areas
Sponsors
Leads: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

This content was sourced from clinicaltrials.gov